» Articles » PMID: 25367033

Pericellular Proteolysis in Cancer

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2014 Nov 5
PMID 25367033
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Pericellular proteases have long been associated with cancer invasion and metastasis due to their ability to degrade extracellular matrix components. Recent studies demonstrate that proteases also modulate tumor progression and metastasis through highly regulated and complex processes involving cleavage, processing, or shedding of cell adhesion molecules, growth factors, cytokines, and kinases. In this review, we address how cancer cells, together with their surrounding microenvironment, regulate pericellular proteolysis. We dissect the multitude of mechanisms by which pericellular proteases contribute to cancer progression and discuss how this knowledge can be integrated into therapeutic opportunities.

Citing Articles

On-chip fabrication of tailored 3D hydrogel scaffolds to model cancer cell invasion and interaction with endothelial cells.

Cantoni F, Barbe L, Roy A, Wicher G, Simonsson S, Forsberg-Nilsson K APL Bioeng. 2024; 8(4):046113.

PMID: 39634677 PMC: 11617029. DOI: 10.1063/5.0227135.


[Research Progress on the Mechanism and Diagnostic Markers of Bone Metastasis 
in Small Cell Lung Cancer].

Xiang X, Nan Y Zhongguo Fei Ai Za Zhi. 2024; 27(9):697-703.

PMID: 39492585 PMC: 11534582. DOI: 10.3779/j.issn.1009-3419.2024.106.24.


The endolysosomal system in conventional and unconventional protein secretion.

Neel E, Chiritoiu-Butnaru M, Fargues W, Denus M, Colladant M, Filaquier A J Cell Biol. 2024; 223(9).

PMID: 39133205 PMC: 11318669. DOI: 10.1083/jcb.202404152.


A genetically-encoded fluorescence-based reporter to spatiotemporally investigate mannose-6-phosphate pathway.

Bhat M, Nambiar A, Edakkandiyil L, Abraham I, Sen R, Negi M Mol Biol Cell. 2024; 35(8):mr6.

PMID: 38888935 PMC: 11321044. DOI: 10.1091/mbc.E23-09-0344.


Cathepsins and cancer risk: a Mendelian randomization study.

Deng T, Lu X, Jia X, Du J, Wang L, Cao B Front Endocrinol (Lausanne). 2024; 15:1428433.

PMID: 38883596 PMC: 11176415. DOI: 10.3389/fendo.2024.1428433.


References
1.
Yin M, Soikkeli J, Jahkola T, Virolainen S, Saksela O, Holtta E . TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells. Am J Pathol. 2012; 181(6):2202-16. DOI: 10.1016/j.ajpath.2012.08.027. View

2.
Moser B, Wolf M, Walz A, Loetscher P . Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 2004; 25(2):75-84. DOI: 10.1016/j.it.2003.12.005. View

3.
Lopez-Otin C, Hunter T . The regulatory crosstalk between kinases and proteases in cancer. Nat Rev Cancer. 2010; 10(4):278-92. DOI: 10.1038/nrc2823. View

4.
Xu J, Rodriguez D, Petitclerc E, Kim J, Hangai M, Moon Y . Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol. 2001; 154(5):1069-79. PMC: 2196184. DOI: 10.1083/jcb.200103111. View

5.
Guo Y, Xu F, Lu T, Duan Z, Zhang Z . Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev. 2012; 38(7):904-10. DOI: 10.1016/j.ctrv.2012.04.007. View